obesity drug news today glp-1 october 27 2025 McKee's proposed FY2027 budget drops drugs for weight loss from Medicaid • Rhode Island Current Obesity GLP-1 Market Size to
Description
Headaches were also often reported in the trials

We don't have any really true randomized controlled trials. Does Semaglutide Affect Breast Milk Supply

For patients with known diabetic retinopathy who are candidates for GLP-1 therapy, additional precautions are warranted

Notably, research indicates that individuals most interested in trying GLP-1 medications, and willing to accept common side effects, are those who report greater body shame, body surveillance, weight concerns, anti-fat bias, disordered eating behaviors, and higher BMIs, alongside lower body appreciation and body neutrality (Markey et al., 2025)

In fact, 1 year after discontinuing the use of GLP-1 drugs, patients regain two-thirds of their prior weight loss

doi: 10.1111/bph.13323 69 FulurijaALutzTASladkoKOstoMWielingaPYBachmannMFet al
